Form 8-K - Current report:
SEC Accession No. 0000950170-24-019730
Filing Date
2024-02-26
Accepted
2024-02-26 07:00:25
Documents
12
Period of Report
2024-02-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20240226.htm   iXBRL 8-K 47070
  Complete submission text file 0000950170-24-019730.txt   161768

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20240226.xsd EX-101.SCH 26927
13 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20240226_htm.xml XML 4690
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 24673510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)